547 related articles for article (PubMed ID: 29271260)
21. Proteomic portrait of human breast cancer progression identifies novel prognostic markers.
Geiger T; Madden SF; Gallagher WM; Cox J; Mann M
Cancer Res; 2012 May; 72(9):2428-39. PubMed ID: 22414580
[TBL] [Abstract][Full Text] [Related]
22. Label-free proteomic analysis of breast cancer molecular subtypes.
Panis C; Pizzatti L; Herrera AC; Corrêa S; Binato R; Abdelhay E
J Proteome Res; 2014 Nov; 13(11):4752-72. PubMed ID: 25221861
[TBL] [Abstract][Full Text] [Related]
23. High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers.
Terkelsen T; Pernemalm M; Gromov P; Børresen-Dale AL; Krogh A; Haakensen VD; Lethiö J; Papaleo E; Gromova I
Mol Oncol; 2021 Feb; 15(2):429-461. PubMed ID: 33176066
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer subtyping from plasma proteins.
Zhang F; Chen JY
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S6. PubMed ID: 23369492
[TBL] [Abstract][Full Text] [Related]
25. Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.
Miah S; Banks CA; Adams MK; Florens L; Lukong KE; Washburn MP
Mol Biosyst; 2016 Dec; 13(1):42-55. PubMed ID: 27891540
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays.
Boyd ZS; Wu QJ; O'Brien C; Spoerke J; Savage H; Fielder PJ; Amler L; Yan Y; Lackner MR
Mol Cancer Ther; 2008 Dec; 7(12):3695-706. PubMed ID: 19056674
[TBL] [Abstract][Full Text] [Related]
27. Implications of functional proteomics in breast cancer.
Chae YK; Gonzalez-Angulo AM
Oncologist; 2014 Apr; 19(4):328-35. PubMed ID: 24664486
[TBL] [Abstract][Full Text] [Related]
28. Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional Proteomics.
Lin TY; Wang PW; Huang CH; Yang PM; Pan TL
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846884
[TBL] [Abstract][Full Text] [Related]
29. Quantitative proteomic analysis of HER2 normal and overexpressing MCF-7 breast cancer cells revealed proteomic changes accompanied with HER2 gene amplification.
Tang Y; Mackey J; Lai R; Ghosh S; Santos C; Graham K; Damaraju S; Pasdar M; Li L
J Proteomics; 2013 Oct; 91():200-9. PubMed ID: 23851309
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
[TBL] [Abstract][Full Text] [Related]
31. Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance.
Kim HK; Park KH; Kim Y; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Lee JE; Ahn JS; Im YH; Yu JH; Park YH
Cancer Res Treat; 2019 Apr; 51(2):737-747. PubMed ID: 30189722
[TBL] [Abstract][Full Text] [Related]
32. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
Creighton CJ; Fu X; Hennessy BT; Casa AJ; Zhang Y; Gonzalez-Angulo AM; Lluch A; Gray JW; Brown PH; Hilsenbeck SG; Osborne CK; Mills GB; Lee AV; Schiff R
Breast Cancer Res; 2010; 12(3):R40. PubMed ID: 20569503
[TBL] [Abstract][Full Text] [Related]
33. Receptor-based Surrogate Subtypes and Discrepancies with Breast Cancer Intrinsic Subtypes: Implications for Image Biomarker Development.
Jamshidi N; Yamamoto S; Gornbein J; Kuo MD
Radiology; 2018 Oct; 289(1):210-217. PubMed ID: 30040052
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of the intrinsic molecular subtypes of breast cancer.
Prat A; Pineda E; Adamo B; Galván P; Fernández A; Gaba L; Díez M; Viladot M; Arance A; Muñoz M
Breast; 2015 Nov; 24 Suppl 2():S26-35. PubMed ID: 26253814
[TBL] [Abstract][Full Text] [Related]
35. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.
Sweeney C; Bernard PS; Factor RE; Kwan ML; Habel LA; Quesenberry CP; Shakespear K; Weltzien EK; Stijleman IJ; Davis CA; Ebbert MT; Castillo A; Kushi LH; Caan BJ
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):714-24. PubMed ID: 24521995
[TBL] [Abstract][Full Text] [Related]
36. Prediction of the clinicopathological subtypes of breast cancer using a fisher discriminant analysis model based on radiomic features of diffusion-weighted MRI.
Ni M; Zhou X; Liu J; Yu H; Gao Y; Zhang X; Li Z
BMC Cancer; 2020 Nov; 20(1):1073. PubMed ID: 33167903
[TBL] [Abstract][Full Text] [Related]
37. Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer.
Pavlou MP; Dimitromanolakis A; Martinez-Morillo E; Smid M; Foekens JA; Diamandis EP
J Proteome Res; 2014 Jun; 13(6):2897-909. PubMed ID: 24799281
[TBL] [Abstract][Full Text] [Related]
38. Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
Prat A; Brase JC; Cheng Y; Nuciforo P; Paré L; Pascual T; Martínez D; Galván P; Vidal M; Adamo B; Hortobagyi GN; Baselga J; Ciruelos E
Oncologist; 2019 Jul; 24(7):893-900. PubMed ID: 30679318
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
Prat A; Cheang MC; Galván P; Nuciforo P; Paré L; Adamo B; Muñoz M; Viladot M; Press MF; Gagnon R; Ellis C; Johnston S
JAMA Oncol; 2016 Oct; 2(10):1287-1294. PubMed ID: 27281556
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
